In non-cancerous conditions, ANO1 contributes to the pathogenesis of asthma, cystic fibrosis, and hypertension by regulating ion homeostasis and membrane potential, positioning it as a promising therapeutic target. The gene discussed is ANO1; the disease is hypertensive disorder.